Tempus AI Inc TEM:NASDAQ
RT Quote | Last NYSE Arca, VOL From CTA | USD
After Hours: Last | 06/03/26 EDT46.65
-0.86 (-1.81%)
-0.86 (-1.81%)Volume
310,687
Close
47.51-2.11 (-4.25%)
-2.11 (-4.25%)Volume
5,990,331
52 week range
41.73 - 104.32
- Open48.50
- Day High48.65
- Day Low46.37
- Prev Close49.62
- 52 Week High104.32
- 52 Week High Date10/09/25
- 52 Week Low41.73
- 52 Week Low Date03/30/26
Latest On Tempus AI Inc
Key Stats
- Market Cap8.531B
- Shares Out179.56M
- 10 Day Average Volume6.49M
- Dividend-
- Dividend Yield-
- Beta-
Latest On Tempus AI Inc
KEY STATS
- Open48.50
- Day High48.65
- Day Low46.37
- Prev Close49.62
- 52 Week High104.32
- 52 Week High Date10/09/25
- 52 Week Low41.73
- 52 Week Low Date03/30/26
- Market Cap8.531B
- Shares Out179.56M
- 10 Day Average Volume6.49M
- Dividend-
- Dividend Yield-
- Beta-
RATIOS/PROFITABILITY
- EPS (TTM)-1.71
- P/E (TTM)-27.75
- Fwd P/E (NTM)-159.97
- EBITDA (TTM)-158.193M
- ROE (TTM)-81.58%
- Revenue (TTM)1.364B
- Gross Margin (TTM)63.39%
- Net Margin (TTM)-22.20%
- Debt To Equity (MRQ)296.15%
EVENTS
- Earnings Date07/31/2026(est)
- Ex Div Date-
- Div Amount-
- Split Date-
- Split Factor-
Content From Our Affiliates
Related Video
watch now
Profile
MORETempus AI, Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. It offers AI-enabled precision medicine solutions to physicians to deliver personalized patient care and, in parallel, facilitates discovery, development and delivery of optimal therapeutics. It provides three product lines: Genomics, Data and artificial intelligence applications (AI). The Genomics product line leverages its...
Eric Lefkofsky J.D.
Chairman of the Board, Chief Executive Officer, Founder
James Rogers
Chief Financial Officer
Andrew Polovin J.D.
Executive Vice President, Chief Legal Officer and Secretary
Address
600 West Chicago Avenue, Suite 510
Chicago, IL
60654
United States